Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.

Spironolactone in anti-acne cream can cause allergic skin reactions in some people.

Upadacitinib effectively treats severe alopecia areata and is safe.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

PRP treatment lacks strong evidence for routine use due to poor study quality.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Switching to generic tacrolimus was safe, effective, and saved money.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Non-itchy rashes can indicate serious diseases like lupus.

PUVA-turban therapy can help some people with severe alopecia areata regrow hair.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Etanercept effectively treated a severe skin condition when other treatments failed.

Oral alitretinoin is effective for certain types of chronic hand eczema, with mild side effects.

Early diagnosis and treatment of calcinosis cutis in lupus patients is crucial due to its rarity and potential complications.

Topical Ruxolitinib may safely treat severe hair loss.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.